Do Depressive Symptoms Moderate the Effects of Exercise Self-efficacy on Physical Activity Among Patients With Coronary Heart Disease?

Do Depressive Symptoms Moderate the Effects of Exercise Self-efficacy on Physical Activity Among Patients With Coronary Heart Disease? J Cardiovasc Nurs. 2018 May 24;: Authors: Siow E, Leung DYP, Wong EML, Lam WH, Lo SM Abstract BACKGROUND: Exercise self-efficacy is an important predictor of physical activity. Patients with coronary heart disease are at risk of developing depressive symptoms that could further weaken their self-efficacy and interfere with their ability to engage in physical activity. OBJECTIVE: The aim of this study was to examine the relationship between depressive symptoms, exercise self-efficacy, and physical activity among patients with coronary heart disease and how the efficacy-activity relationship is affected by the patient's level of depression. METHODS: A survey was conducted on 149 participants at the time of discharge from the emergency and in-patient medical wards at 2 regional hospitals. RESULTS: The sample was mostly male, married, living with families, and of lower socioeconomic status. The mean exercise self-efficacy was 4.26 ± 2.73, and the median physical activity was 12 (interquartile range, 6-21). Approximately 26% of participants had high depressive symptoms. Those with more depressive symptoms reported lower self-efficacy scores and lower physical activity. In multivariate regressions, self-efficacy was an independent predictor of physical activity (b = 1.48, P
Source: The Journal of Cardiovascular Nursing - Category: Nursing Authors: Tags: J Cardiovasc Nurs Source Type: research

Related Links:

This study was conducted to assess the health-related quality of life (HRQOL) and perceived health status of the Turkish population.MethodsThe data came from a nationwide survey, which was conducted by Ministry of Health on prevalence and risk factors for chronic diseases in Turkey, with a representative random sample of 18,477 people aged  ≥ 15 years from Turkey. Each family physician invited two individuals selected from their registered population to the Family Health Center, conducted the survey by face to face interviews using an electronic form. HRQOL was determined using EQ-5D-3L scale.ResultsI...
Source: Quality of Life Research - Category: Health Management Source Type: research
Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort, Published online: 19 March 2019; doi:10.1038/s41380-019-0395-3Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort
Source: Molecular Psychiatry - Category: Psychiatry Authors: Source Type: research
Generalised anxiety disorder (GAD) is a frequent and severe anxiety disorder among older adults. GAD increases the risk of developing other disorders such as depression and coronary heart disease. Older adults...
Source: Trials - Category: General Medicine Authors: Tags: Study protocol Source Type: research
Abstract Child Sexual Abuse (CSA) is a global public health problem that has been found to be linked to negative health outcomes. The aim of this study is to examine the prevalence of different forms of CSA and its impact on chronic diseases, mental health disorders, and health-risk behaviors among adults in Saudi Arabia (SA). A cross-sectional, national survey utilizing Adverse Childhood Experiences International Questionnaire (ACE-IQ) was conducted in SA. Adults (N=10,156) aged ≥18 years were invited to participate. The relationship between CSA variables and outcomes were calculated. The prevalence of life ti...
Source: Child Abuse and Neglect - Category: Child Development Authors: Tags: Child Abuse Negl Source Type: research
Medication side-effects can seem unbearable at times: dry mouth, nausea, dizziness, constipation. Certain prescriptions can also increase our risks for developing chronic conditions like thyroid disease and diabetes. Three years ago, I decided that the pills’ side-effects weren’t worth the relief they brought, so I slowly weaned off all my medication. I then plummeted into a severe depression that ended up taking a far greater toll on my health than the nuisance of my drugs. You may be justifiably concerned about how your mood stabilizer and antidepressant are altering your biochemistry, but also consider the g...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Depression General Medications Antidepressant Cognitive Decline Diabetes Mood Stabilizer Source Type: blogs
Depression and anxiety are prevalent and associated with a worse prognosis in coronary heart disease (CHD) patients. However, the influence of disease severity on mood symptoms is unknown. The specific associa...
Source: BMC Psychiatry - Category: Psychiatry Authors: Tags: Research article Source Type: research
CONCLUSIONS: Patients with clinical phenotype of FH are associated with subjectively perceived depression, particularly among FH patients with a family history of CHD. PMID: 30876531 [PubMed - in process]
Source: Atherosclerosis Supplements - Category: Cardiology Authors: Tags: Atheroscler Suppl Source Type: research
Conditions:   Coronary Heart Disease;   Percutaneous Coronary Intervention;   Depression Intervention:   Procedure: percutaneous coronary intervention Sponsor:   Nanjing First Hospital, Nanjing Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: April 2019Source: Biomedicine &Pharmacotherapy, Volume 112Author(s): Huan Ma, Yu Wang, YunLian Xue, Daozheng Huang, Yongjie Kong, Xujie Zhao, Minzhou ZhangAbstractA large proportion of patients with coronary artery disease (CAD) suffer from depression or anxiety symptoms and this is associated with increased mortality [1]. This double-blinded, randomized, placebo-controlled, clinical trial (ChiCTR-IPR-17010940) aimed to explore whether Xinkeshu tablets can reduce anxiety or depressive symptoms in CAD patients and how this is related to the concentration of plasma cytokines. Sixty patients with CAD and...
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
Abstract A large proportion of patients with coronary artery disease (CAD) suffer from depression or anxiety symptoms and this is associated with increased mortality [1]. This double-blinded, randomized, placebo-controlled, clinical trial (ChiCTR-IPR-17010940) aimed to explore whether Xinkeshu tablets can reduce anxiety or depressive symptoms in CAD patients and how this is related to the concentration of plasma cytokines. Sixty patients with CAD anda Hospital Anxiety and Depression Scale (HADS-a/HADS-d) score of ≥8 were treated with Xinkeshu tablets or placebo for 12 weeks following percutaneous revascularizat...
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Tags: Biomed Pharmacother Source Type: research
More News: Cardiology | Cardiovascular | Coronary Heart Disease | Depression | Emergency Medicine | Heart | Heart Disease | Nurses | Nursing | Sports Medicine | Study